Akouos, Inc.
Clinical trials sponsored by Akouos, Inc., explained in plain language.
-
Gene therapy for ear tumors: Long-Term safety under review
Disease control ENROLLING_BY_INVITATIONThis study follows 100 people with vestibular schwannoma (a non-cancerous ear tumor) who previously received a gene therapy called AAVAnc80-antiVEGF. Researchers will monitor for late side effects and measure tumor size changes over time using MRI scans. The goal is to understand…
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Gene therapy for deafness: researchers track long-term safety and hearing gains
Disease control ENROLLING_BY_INVITATIONThis study follows 30 people who previously received a gene therapy (AAVAnc80-hOTOF) for hearing loss caused by otoferlin gene mutations. Researchers will monitor safety over the long term, checking for late side effects, and measure hearing improvements using brain response test…
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC